Dysregulation of TLR2 Serves as a Prognostic Biomarker in Breast Cancer and Predicts Resistance to Endocrine Therapy in the Luminal B Subtype

Background: Breast cancer (BCa) is a serious global health burden among females, and the development of resistance represents an important challenge to BCa treatment. Here, we examined the expression of toll-like receptor 2 (TLR2) in BCa patients and the prognostic value of TLR2 for predicting endoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yunmei, Liu, Shuguang, Zhang, Yanjun, Yang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203473/
https://www.ncbi.nlm.nih.gov/pubmed/32426275
http://dx.doi.org/10.3389/fonc.2020.00547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203473/
https://www.ncbi.nlm.nih.gov/pubmed/32426275
http://dx.doi.org/10.3389/fonc.2020.00547

Ejemplares similares